Another Kardashian FDA letter: Biohaven smacked for Khloe's Nurtec migraine med claims
Reality star Khloe Kardashian’s appearance on "The View" talk show earned Biohaven Pharmaceuticals loads of media impressions and mentions last summer—but now it's earned | Reality TV superstar Khloe Kardashian’s appearance on "The View" talk show earned Biohaven lots of media mentions last...
Reality star Khloe Kardashian’s appearance on "The View" talk show earned Biohaven Pharmaceuticals loads of media impressions and mentions last summer—but now it's earned the pharma company an FDA slapdown.
Kardashian appeared on the morning talk show last July just after she signed on as a Nurtec spokescelebrity. During the seven-minute segment, she talked about her daughter, her family’s reality series and her migraine headaches.
All fine so far. But she also called Nurtec ODT a “game changer,” claimed it works in 15-20 minutes and said it doesn’t give her rebound headaches like the other migraine meds she’s used. All while being recognized as a paid spokesperson for Biohaven and Nurtec.
We been through this last year when politicians were accused of using press conferences to push unproven treatments. Now the FDA has issued a warning to the Kardashians and Biohaven Pharmaceuticals over claims in their advertising.